Geistlich Pharma's Chinese subsidiary hit with fine by market regulator for RPM (English version)
Geistlich Trading (Beijing), a subsidiary of Geistlich Pharma, has been fined 9.1 million yuan ($1.4 million) by the Beijing municipal Administration for Market Regulation for imposing minimum resale price restrictions on...To view the full article, register now.
Already a subscriber? Click here to view full article